Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · U.S. Physical Therapy (USPH)

U.S. Physical Therapy appoints Myra Davis to board, effective October 1, 2026

Neutral Impact 2 of 5 leadership Written later

U.S. Physical Therapy's Board approved the appointment of Myra Davis, executive vice president and chief information innovation officer at Texas Children's Hospital, as a director effective October 1, 2026. The filing reports no committee assignment yet and no related-party transactions, and it does not disclose financial results.

Key points

  • Board approved the appointment on September 15, 2026, effective October 1, 2026
  • Davis, 61, has been at Texas Children's Hospital since 2003 and has held her current role since 2023
  • Davis will receive an annual cash retainer and annual equity grant under the proxy statement's Director Compensation terms
  • Chairman and CEO Chris Reading said her technology and innovation background will add perspective to the Board

The filing

CompanyU.S. Physical Therapy (USPH)
Form8-K, current report
Filed with the SECSep 21, 2026, 4:17 PM ET
Accession number0000885978-26-000057

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.